Special: America’s Rich Dumping Tech Stocks & Cash… and Buying THIS

  • Facebook
  • Twitter
  • Podcast

Author: Editor Team

After news was released, shares of Seattle Genetics, Inc. (Nasdaq: SGEN) jumped more than 4.5%. Business Wire reported the reason behind the price move, “Seattle Genetics, Inc. and Astellas Pharma Inc. announced initial results from the phase 1 clinical trial EV-103. Forty-five patients were evaluated for safety with the combination...